PLX
$0.44
Protalix Biotherapeutics
($.01)
(2.22%)
PLX
Earnings Whisper ®
N/A
2nd Quarter June 2018
Consensus:  ($0.05)
Revenue:  $7.00 Mil
Wednesday
Aug 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PLX reports earnings?
Beat
Meet
Miss

Where is PLX's stock price going from here?
Up
Flat
Down
Stock chart of PLX
Analysts
Summary of analysts' recommendations for PLX
Score
Grade
Pivots
Resistance
$0.48
$0.47
$0.46

$0.45

Support
$0.44
$0.43
$0.42
Tweet
Growth
Description
ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements, they have control over all non-orthodontic functions of the PA Contractors, including administrative, management, billing and support functions.
Peers
BiogenGilead SciencesBluebird BioAmgenSeattle GeneticsNeurocrine BiosciencesQiagen N.V.Bio-TechneBioCryst PharmaceuticalsNovavax